Literature DB >> 365388

A controlled field trial of plain and aluminium hydroxide-adsorbed cholera vaccines in Surabaya, Indonesia, during 1973--75.

J S Saroso, W Bahrawi, H Witjaksono, R L Budiarso, Z Bencić, W E Dewitt, C Z Gomez.   

Abstract

A controlled field trial comparing the effectiveness of a plain cholera vaccine with that of a vaccine adsorbed to aluminium hydroxide was carried out in a cholera-endemic area of Indonesia during 1973-75. Tetanus toxoid adsorbed to aluminium phosphate was used as the control. In vaccinees aged 1-4 years, the adsorbed cholera vaccine provided about 88% protection for 6 months following vaccination and still provided about 50% protection between 11 and 14 months after vaccination. In the same age group, the plain vaccine provided only 53% protection during the first 6 months and no appreciable protection beyond that period. In those aged 5 years and over, both vaccines provided 50-60% protection throughout the period of observation (14 months). Neither vaccine caused any serious side effects.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 365388      PMCID: PMC2395651     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  4 in total

1.  Preparation and laboratory tests of oil-adjuvant cholera vaccine.

Authors:  H Ogonuki; S Hashizume; B Takashashi
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

2.  Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. I. Study design and results of the first year of observation.

Authors:  W H Mosley; W M McCormack; M Fahimuddin; K M Aziz; A S Rahman; A K Chowdhury; A R Martin; J C Feeley; R A Phillips
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

3.  A serological survey for cholera antibodies in rural east Pakistan. 2. A comparison of antibody titres in the innunized and control populationd of a cholera-vaccine field-trial area and the relation of antibody titre to cholera case rate.

Authors:  W H Mosley; A S Benenson; R Barui
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

4.  Field trials of monovalent Ogawa and Inaba cholera vaccines in rural Bangladesh--three years of observation.

Authors:  W H Mosley; K M Aziz; A S Rahman; A K Chowdhury; A Ahmed
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

  4 in total
  9 in total

1.  Immunogenicity of two formulations of oral cholera vaccine comprised of killed whole vibrios and the B subunit of cholera toxin.

Authors:  S Migasena; V Desakorn; P Suntharasamai; P Pitisuttitham; B Prayurahong; W Supanaranond; R E Black
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

Review 2.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors:  M M Levine; J B Kaper; R E Black; M L Clements
Journal:  Microbiol Rev       Date:  1983-12

3.  Local histopathological reactions to aluminum-adsorbed tetanus toxoid.

Authors:  N Goto; K Akama
Journal:  Naturwissenschaften       Date:  1984-08

Review 4.  Vibrio cholerae: lessons for mucosal vaccine design.

Authors:  Anne L Bishop; Andrew Camilli
Journal:  Expert Rev Vaccines       Date:  2011-01       Impact factor: 5.217

5.  Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin.

Authors:  R E Black; M M Levine; M L Clements; C R Young; A M Svennerholm; J Holmgren
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

Review 6.  Critical analysis of compositions and protective efficacies of oral killed cholera vaccines.

Authors:  Shahjahan Kabir
Journal:  Clin Vaccine Immunol       Date:  2014-07-23

7.  A controlled field trial of an aluminum phosphate-adsorbed cholera vaccine in Calcutta.

Authors:  S C Pal; B C Deb; P G Sen Gupta; S P De; B K Sircar; D Sen; S N Sikdar
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

Review 8.  Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected).

Authors:  Patricia M Graves; Jonathan J Deeks; Vittorio Demicheli; Tom Jefferson
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04

9.  Prevention of cholera.

Authors:  Noel W Preston
Journal:  Lancet       Date:  2004-03-13       Impact factor: 79.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.